MED12 exon 2 mutations are common in uterine leiomyomas from South African patients

Oncotarget

Volumn 2, Issue 12, 2011, Pages 966-969

  Mäkinen, Netta ^a   Heinonen, Hanna Riikka ^a   Moore, Shane ^b   Tomlinson, Ian P M ^c   Van Der Spuy, Zephne M ^b   Aaltonen, Lauri A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MED12 PROTEIN, HUMAN; MEDIATOR COMPLEX;

ADULT; ARTICLE; FEMALE; GENETICS; HUMAN; LEIOMYOMA; MIDDLE AGED; MUTATION; NEGRO; NUCLEOTIDE SEQUENCE; SOUTH AFRICA; UTERUS CANCER;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; LEIOMYOMA; MEDIATOR COMPLEX; MIDDLE AGED; MUTATION; SOUTH AFRICA; UTERINE NEOPLASMS;

EID: 84858059395     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.370     Document Type: Article

References (14)

1. Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Practice & Research Clinical Obstetrics & Gynaecology. 2008; 22: 571-88.
2. Stewart EA. Uterine fibroids. Lancet. 2001; 357: 293-98.
3. Flynn M, Jamison M, Datta S, Myers E. Health care resource use for uterine fibroid tumors in the United States. American Journal of Obstetrics and Gynecology. 2006;195: 955-64.
4. Hartmann KE, Birnbaum H, Ben-Hamadi R, Wu EQ, Farrell MH, Spalding J, Stang P. Annual costs associated with diagnosis of uterine leiomyomata. Obstetrics and Gynecology. 2006; 108: 930-37.
5. Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. American Journal of Obstetrics and Gynecology. 2003; 188: 100-7.
6. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett WC, Hunter DJ. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstetrics and Gynecology. 1997; 90: 967-73.
7. Huyck KL, Panhuysen CI, Cuenco KT, Zhang J, Goldhammer H, Jones ES, Somasundaram P, Lynch AM, Harlow BL, Lee H, Stewart EA, Morton CC. The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters.American Journal of Obstetrics and Gynecology. 2008; 198; 168.e1-e9.
8. Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL, Rosenberg L. Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women's Health Study. Human Reproduction (Oxford, England). 2004; 19: 1746-54.
9. Wise LA, Palmer JR, Spiegelman D, Harlow BL, Stewart EA, Adams-Campbell LL, Rosenberg L. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology (Cambridge, Mass.). 2005; 16: 346-54.
10. Templeman C, Marshall SF, Clarke CA, Henderson KD, Largent J, Neuhausen S, Reynolds P, Ursin G, Bernstein L. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertility and Sterility. 2009; 92: 1436-46.
11. Mäkinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, Gentile M, Yan J, Enge M, Taipale M, Aavikko M, Katainen R, Virolainen E, Böhling T, Koski TA, Launonen V, Sjöberg J, Taipale J, Vahteristo P, Aaltonen LA. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011; 334: 252-55.
12. Taatjes DJ. The human Mediator complex: a versatile, genome-wide regulator of transcription. Trends in Biochemical Sciences. 2010; 35: 315-22.
13. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. The Journal of Reproductive Medicine. 1996; 41: 483-90.
14. Al-Hendy A, Salama SA. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. Journal of the Society for Gynecologic Investigation. 2006; 13: 136-44.